Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2932049, 6 pages
http://dx.doi.org/10.1155/2016/2932049
Research Article

Lack of Associations between XPC Gene Polymorphisms and Neuroblastoma Susceptibility in a Chinese Population

1Department of Pediatric Surgery, Foshan Maternity and Children’s Healthcare Hospital Affiliated to Southern Medical University, Foshan, China
2Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, China
3Molecular Epidemiology Laboratory and Department of Laboratory Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, China

Received 11 July 2016; Accepted 27 September 2016

Academic Editor: Hai-Feng Pan

Copyright © 2016 Jintao Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Smith, N. L. Seibel, S. F. Altekruse et al., “Outcomes for children and adolescents with cancer: challenges for the twenty-first century,” Journal of Clinical Oncology, vol. 28, no. 15, pp. 2625–2634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Maris, M. D. Hogarty, R. Bagatell, and S. L. Cohn, “Neuroblastoma,” The Lancet, vol. 369, no. 9579, pp. 2106–2120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. M. Brodeur, J. Pritchard, F. Berthold et al., “Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment,” Journal of Clinical Oncology, vol. 11, no. 8, pp. 1466–1477, 1993. View at Google Scholar · View at Scopus
  4. P.-P. Bao, K. Li, C.-X. Wu et al., “Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002–2010,” Zhonghua Er Ke Za Zhi, vol. 51, no. 4, pp. 288–294, 2013. View at Google Scholar · View at Scopus
  5. F. Berthold, J. Boos, S. Burdach et al., “Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial,” The Lancet Oncology, vol. 6, no. 9, pp. 649–658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Maris, “Recent advances in neuroblastoma,” The New England Journal of Medicine, vol. 362, no. 23, pp. 2154–2211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Frazer, S. S. Murray, N. J. Schork, and E. J. Topol, “Human genetic variation and its contribution to complex traits,” Nature Reviews Genetics, vol. 10, no. 4, pp. 241–251, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. T. A. Manolio, “Genomewide association studies and assessment of the risk of disease,” The New England Journal of Medicine, vol. 363, no. 2, pp. 166–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Maris, Y. P. Mosse, J. P. Bradfield et al., “Chromosome 6p22 locus associated with clinically aggressive neuroblastoma,” The New England Journal of Medicine, vol. 358, no. 24, pp. 2585–2593, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. J. Diskin, M. Capasso, R. W. Schnepp et al., “Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma,” Nature Genetics, vol. 44, no. 10, pp. 1126–1130, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Capasso, M. Devoto, C. Hou et al., “Common variations in BARD1 influence susceptibility to high-risk neuroblastoma,” Nature Genetics, vol. 41, no. 6, pp. 718–723, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Wang, S. J. Diskin, H. Zhang et al., “Integrative genomics identifies LMO1 as a neuroblastoma oncogene,” Nature, vol. 469, no. 7329, pp. 216–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. B. Nguyễn, S. J. Diskin, M. Capasso et al., “Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci,” PLoS Genetics, vol. 7, no. 3, Article ID e1002026, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Han, Y. Zhou, R. Zhong et al., “Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population,” PLoS ONE, vol. 8, no. 8, Article ID e71656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Capasso, S. Diskin, F. Cimmino et al., “Common genetic variants in NEFL influence gene expression and Neuroblastoma risk,” Cancer Research, vol. 74, no. 23, pp. 6913–6924, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jin, H. Wang, W. Han et al., “Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population,” Tumor Biology, vol. 37, no. 3, pp. 3739–3747, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. R. D. Wood, M. Mitchell, J. Sgouros, and T. Lindahl, “Human DNA repair genes,” Science, vol. 291, no. 5507, pp. 1284–1289, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. E. C. Friedberg, “How nucleotide excision repair protects against cancer,” Nature Reviews Cancer, vol. 1, no. 1, pp. 22–33, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Cleaver, “Defective repair replication of DNA in xeroderma pigmentosum,” Nature, vol. 218, no. 5142, pp. 652–656, 1968. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Riedl, F. Hanaoka, and J.-M. Egly, “The comings and goings of nucleotide excision repair factors on damaged DNA,” EMBO Journal, vol. 22, no. 19, pp. 5293–5303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Volker, M. J. Moné, P. Karmakar et al., “Sequential assembly of the nucleotide excision repair factors in vivo,” Molecular Cell, vol. 8, no. 1, pp. 213–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. H. J. Hoeijmakers, “Genome maintenance mechanisms for preventing cancer,” Nature, vol. 411, no. 6835, pp. 366–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. De Boer and J. H. J. Hoeijmakers, “Nucleotide excision repair and human syndromes,” Carcinogenesis, vol. 21, no. 3, pp. 453–460, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. W. L. de Laat, N. G. J. Jaspers, and J. H. J. Hoeijmakers, “Molecular mechanism of nucleotide excision repair,” Genes & Development, vol. 13, no. 7, pp. 768–785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. R. D. Wood, “Nucleotide excision repair in mammalian cells,” Journal of Biological Chemistry, vol. 272, no. 38, pp. 23465–23468, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Paszkowska-Szczur, R. J. Scott, P. Serrano-Fernandez et al., “Xeroderma pigmentosum genes and melanoma risk,” International Journal of Cancer, vol. 133, no. 5, pp. 1094–1100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Paszkowska-Szczur, R. J. Scott, B. Górski et al., “Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population,” Molecular Biology Reports, vol. 42, no. 3, pp. 755–764, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Ahmad Aizat, M. S. Siti Nurfatimah, M. M. Aminudin, and R. Ankathil, “XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians,” World Journal of Gastroenterology, vol. 19, no. 23, pp. 3623–3628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Yoshino, S. Takeuchi, T. Katoh, and Y. Kuroda, “XPC intron11 C/A polymorphism as a risk factor for prostate cancer,” Environmental Health and Preventive Medicine, vol. 21, no. 2, pp. 100–104, 2016. View at Publisher · View at Google Scholar
  30. B. Wang, Q. Xu, H. W. Yang, L. P. Sun, and Y. Yuan, “The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk,” Oncotarget, vol. 7, no. 15, pp. 20357–20367, 2016. View at Publisher · View at Google Scholar
  31. C. Mei, M. Hou, S. Guo et al., “Polymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese people,” Thoracic Cancer, vol. 5, no. 3, pp. 232–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Liu, L. Sun, Q. Xu et al., “Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks,” Oncotarget, vol. 7, no. 6, pp. 6972–6983, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. J. He, F. Wang, J. Zhu et al., “Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population,” Journal of Cellular and Molecular Medicine, vol. 20, pp. 1481–1490, 2016. View at Google Scholar
  34. J. He, T. Yang, R. Zhang et al., “Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children,” Journal of Cellular and Molecular Medicine, vol. 20, no. 8, pp. 1534–1541, 2016. View at Publisher · View at Google Scholar
  35. J. He, W. Zhong, J. Zeng et al., “LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population,” Oncotarget, vol. 7, no. 16, pp. 22770–22778, 2016. View at Publisher · View at Google Scholar
  36. R. Zhang, Y. Zou, J. Zhu et al., “The association between GWAS-identified BARD1 gene SNPS and neuroblastoma susceptibility in a Southern Chinese population,” International Journal of Medical Sciences, vol. 13, no. 2, pp. 133–138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. J. He, R. Zhang, Y. Zou et al., “Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population,” Tumor Biology, vol. 37, no. 2, pp. 1635–1639, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. R. X. Hua, Z. J. Zhuo, G. P. Shen et al., “Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population,” Journal of OncoTargets and Therapy, vol. 9, pp. 5513–5519, 2016. View at Publisher · View at Google Scholar
  39. J. He, L.-X. Qiu, M.-Y. Wang et al., “Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations,” Human Genetics, vol. 131, no. 7, pp. 1235–1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. He, M.-Y. Wang, L.-X. Qiu et al., “Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population,” Molecular Carcinogenesis, vol. 52, supplement 1, pp. E70–E79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Akita, Y.-S. Tak, T. Shimura et al., “SUMOylation of xeroderma pigmentosum group C protein regulates DNA damage recognition during nucleotide excision repair,” Scientific Reports, vol. 5, Article ID 10984, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Sugasawa, J. M. Y. Ng, C. Masutani et al., “Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair,” Molecular Cell, vol. 2, no. 2, pp. 223–232, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. J. He, T.-Y. Shi, M.-L. Zhu, M.-Y. Wang, Q.-X. Li, and Q.-Y. Wei, “Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis,” International Journal of Cancer, vol. 133, no. 8, pp. 1765–1775, 2013. View at Publisher · View at Google Scholar · View at Scopus